120 related articles for article (PubMed ID: 36533702)
41. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.
Jacobs I; Gentry-Maharaj A; Burnell M; Manchanda R; Singh N; Sharma A; Ryan A; Seif MW; Amso NN; Turner G; Brunell C; Fletcher G; Rangar R; Ford K; Godfrey K; Lopes A; Oram D; Herod J; Williamson K; Scott I; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Skates SJ; Fallowfield L; Parmar M; Campbell S; Menon U
Lancet Oncol; 2011 Jan; 12(1):38-48. PubMed ID: 21147030
[TBL] [Abstract][Full Text] [Related]
42. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.
Zhao FH; Lin MJ; Chen F; Hu SY; Zhang R; Belinson JL; Sellors JW; Franceschi S; Qiao YL; Castle PE;
Lancet Oncol; 2010 Dec; 11(12):1160-71. PubMed ID: 21075054
[TBL] [Abstract][Full Text] [Related]
43. Developing and validating a multivariable prediction model to improve the diagnostic accuracy in determination of cervical versus endometrial origin of uterine adenocarcinomas: A prospective MR study combining diffusion-weighted imaging and spectroscopy.
Lin G; Lin YC; Wu RC; Yang LY; Lu HY; Tsai SY; Huang YT; Huang YL; Lu KY; Ng KK; Yen TC; Chao A; Lai CH; Hong JH
J Magn Reson Imaging; 2018 Jun; 47(6):1654-1666. PubMed ID: 29178414
[TBL] [Abstract][Full Text] [Related]
44. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.
O'Flynn H; Ryan NAJ; Narine N; Shelton D; Rana D; Crosbie EJ
Nat Commun; 2021 Feb; 12(1):952. PubMed ID: 33574259
[TBL] [Abstract][Full Text] [Related]
46. Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis.
Frias-Gomez J; Benavente Y; Ponce J; Brunet J; Ibáñez R; Peremiquel-Trillas P; Baixeras N; Zanca A; Piulats JM; Aytés Á; Matias-Guiu X; Bosch FX; de Sanjosé S; Alemany L; Costas L;
Cancer Cytopathol; 2020 Nov; 128(11):792-802. PubMed ID: 32202704
[TBL] [Abstract][Full Text] [Related]
47. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
[TBL] [Abstract][Full Text] [Related]
48. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
49. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
[TBL] [Abstract][Full Text] [Related]
50. Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.
Castle PE; Fetterman B; Poitras N; Lorey T; Shaber R; Kinney W
Obstet Gynecol; 2010 Feb; 115(2 Pt 1):243-248. PubMed ID: 20093895
[TBL] [Abstract][Full Text] [Related]
51. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
[TBL] [Abstract][Full Text] [Related]
52. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
53. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
54. DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test.
Herzog C; Sundström K; Jones A; Evans I; Barrett JE; Wang J; Redl E; Schreiberhuber L; Costas L; Paytubi S; Dostalek L; Zikan M; Cibula D; Sroczynski G; Siebert U; Dillner J; Widschwendter M
Clin Epigenetics; 2022 Nov; 14(1):150. PubMed ID: 36414968
[TBL] [Abstract][Full Text] [Related]
55. Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes.
Lee CH; Peng CY; Li RN; Chen YC; Tsai HT; Hung YH; Chan TF; Huang HL; Lai TC; Wu MT
Int J Cancer; 2015 Jan; 136(2):340-9. PubMed ID: 24841989
[TBL] [Abstract][Full Text] [Related]
56. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
57. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
58. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
59. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Zhang X; Pang X; Huang Y; Qian S
Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
[TBL] [Abstract][Full Text] [Related]
60. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
